Advanced Medical Solutions Group (LON:AMS) Stock Passes Below Two Hundred Day Moving Average – Should You Sell?

Advanced Medical Solutions Group plc (LON:AMS) shares passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 216.63 and traded as low as GBX 210. Advanced Medical Solutions Group shares last traded at GBX 217, with a volume of 875,326 shares traded.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the stock. Royal Bank Of Canada restated a “sector perform” rating and issued a GBX 260 target price on shares of Advanced Medical Solutions Group in a report on Thursday, April 9th. Berenberg Bank reiterated a “buy” rating and set a GBX 300 price target on shares of Advanced Medical Solutions Group in a report on Tuesday, May 19th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of GBX 270.25.

Advanced Medical Solutions Group Trading Down 0.2%

The company has a current ratio of 2.79, a quick ratio of 4.58 and a debt-to-equity ratio of 31.50. The company has a market cap of £478.30 million, a PE ratio of 48.78, a PEG ratio of 5.00 and a beta of 0.72. The stock has a 50 day moving average price of GBX 224.16 and a 200 day moving average price of GBX 216.63.

Advanced Medical Solutions Group (LON:AMS) last issued its quarterly earnings results on Wednesday, March 18th. The company reported GBX 11.98 earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a net margin of 4.35% and a return on equity of 3.87%. Sell-side analysts predict that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current fiscal year.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.